IRhythm Technologies EBITDA Margin 2015-2025 | IRTC
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for IRhythm Technologies (IRTC) over the last 10 years. The current EBITDA margin for IRhythm Technologies as of June 30, 2025 is .
| IRhythm Technologies EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $0.66B | $-0.08B | -11.85% |
| 2025-03-31 | $0.62B | $-0.08B | -13.25% |
| 2024-12-31 | $0.59B | $-0.09B | -14.86% |
| 2024-09-30 | $0.56B | $-0.13B | -22.82% |
| 2024-06-30 | $0.54B | $-0.11B | -19.89% |
| 2024-03-31 | $0.51B | $-0.11B | -20.43% |
| 2023-12-31 | $0.49B | $-0.11B | -22.11% |
| 2023-09-30 | $0.47B | $-0.09B | -18.39% |
| 2023-06-30 | $0.45B | $-0.09B | -19.03% |
| 2023-03-31 | $0.43B | $-0.09B | -21.40% |
| 2022-12-31 | $0.41B | $-0.09B | -22.87% |
| 2022-09-30 | $0.38B | $-0.11B | -28.95% |
| 2022-06-30 | $0.36B | $-0.11B | -29.92% |
| 2022-03-31 | $0.34B | $-0.10B | -30.29% |
| 2021-12-31 | $0.32B | $-0.09B | -27.33% |
| 2021-09-30 | $0.32B | $-0.07B | -21.32% |
| 2021-06-30 | $0.31B | $-0.05B | -16.67% |
| 2021-03-31 | $0.28B | $-0.05B | -19.57% |
| 2020-12-31 | $0.27B | $-0.04B | -13.91% |
| 2020-09-30 | $0.25B | $-0.05B | -19.51% |
| 2020-06-30 | $0.23B | $-0.06B | -27.07% |
| 2020-03-31 | $0.23B | $-0.05B | -22.17% |
| 2019-12-31 | $0.21B | $-0.05B | -23.83% |
| 2019-09-30 | $0.20B | $-0.04B | -20.71% |
| 2019-06-30 | $0.18B | $-0.03B | -18.78% |
| 2019-03-31 | $0.16B | $-0.04B | -23.78% |
| 2018-12-31 | $0.15B | $-0.04B | -29.25% |
| 2018-09-30 | $0.13B | $-0.04B | -30.08% |
| 2018-06-30 | $0.12B | $-0.04B | -30.00% |
| 2018-03-31 | $0.11B | $-0.03B | -28.44% |
| 2017-12-31 | $0.10B | $-0.03B | -25.25% |
| 2017-09-30 | $0.09B | $-0.02B | -21.35% |
| 2017-06-30 | $0.08B | $-0.02B | -19.75% |
| 2017-03-31 | $0.07B | $-0.01B | -17.81% |
| 2016-12-31 | $0.07B | $-0.01B | -21.54% |
| 2016-06-30 | $0.04B | $-0.01B | -34.21% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.433B | $0.592B |
| iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.530B | 60.47 |
| Tempus AI (TEM) | United States | $13.989B | 0.00 |
| Doximity (DOCS) | United States | $12.688B | 56.45 |
| Hims & Hers Health (HIMS) | United States | $10.074B | 82.54 |
| Hinge Health (HNGE) | United States | $4.516B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.839B | 41.74 |
| Privia Health (PRVA) | United States | $2.699B | 199.91 |
| Heartflow (HTFL) | $2.367B | 0.00 | |
| Enovis (ENOV) | United States | $1.797B | 9.50 |
| 10x Genomics (TXG) | United States | $1.780B | 0.00 |
| Phreesia (PHR) | United States | $1.770B | 0.00 |
| Omnicell (OMCL) | United States | $1.544B | 29.75 |
| Schrodinger (SDGR) | United States | $1.495B | 0.00 |
| Azenta (AZTA) | United States | $1.446B | 63.10 |
| Clover Health Investments (CLOV) | United States | $1.399B | 0.00 |
| Claritev (CTEV) | United States | $1.189B | 0.00 |
| Evolent Health (EVH) | United States | $1.128B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.666B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.580B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.469B | 140.00 |
| Butterfly Network (BFLY) | United States | $0.383B | 0.00 |
| Carlsmed (CARL) | United States | $0.346B | 0.00 |
| TruBridge (TBRG) | United States | $0.307B | 53.90 |
| Outset Medical (OM) | United States | $0.252B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.244B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.231B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.219B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.203B | 0.00 |
| CapsoVision (CV) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.156B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.148B | 0.00 |
| CareCloud (CCLD) | United States | $0.120B | 5.44 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.074B | 0.00 |
| Pulmonx (LUNG) | United States | $0.069B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| Zhongchao (ZCMD) | China | $0.022B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.017B | 0.00 |
| PROFUSA (PFSA) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |